Search Results - "Wirshing, William C."

Refine Results
  1. 1

    The effects of novel antipsychotics on glucose and lipid levels by WIRSHING, Donna A, BOYD, Jennifer A, MENG, Laura R, BALLON, Jacob S, MARDER, Stephen R, WIRSHING, William C

    Published in The journal of clinical psychiatry (01-10-2002)
    “…The novel antipsychotics are extensively used based on their favorable extrapyramidal side effect profiles. However, accumulating evidence suggests that these…”
    Get full text
    Journal Article
  2. 2

    A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia by PIERRE, Joseph M, PELOIAN, John H, WIRSHING, Donna A, WIRSHING, William C, MARDER, Stephen R

    Published in The journal of clinical psychiatry (01-05-2007)
    “…Negative symptoms are core features of schizophrenia that are functionally debilitating, associated with poor outcomes, and resistant to existing…”
    Get full text
    Journal Article
  3. 3

    Addictive Potential of Quetiapine by MURPHY, DAVID, BAILEY, KIMBERLY, STONE, MICHAEL, WIRSHING, WILLIAM C.

    Published in The American journal of psychiatry (01-07-2008)
    “…The newer "atypical" antipsychotic compounds have generally improved on this subjective intolerability, which has led to the steadily expanding use of these…”
    Get full text
    Journal Article
  4. 4

    Lack of insight in schizophrenia : Impact on treatment adherence by BUCKLEY, Peter F, WIRSHING, Donna A, BHUSHAN, Prameet, PIERRE, Joseph M, RESNICK, Seth A, WIRSHING, William C

    Published in CNS drugs (01-01-2007)
    “…People with schizophrenia commonly lack insight, that is, they are unaware of their illness and the consequences thereof. One of the most important…”
    Get full text
    Journal Article
  5. 5

    Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison by Schooler, Nina R, Marder, Stephen R, Chengappa, K N R, Petrides, Georgios, Ames, Donna, Wirshing, William C, McMeniman, Marjorie, Baker, Robert W, Parepally, Haranath, Umbricht, Daniel, Kane, John M

    Published in The journal of clinical psychiatry (01-05-2016)
    “…Clozapine remains the only medication indicated for refractory schizophrenia. As new antipsychotic drugs become available, their efficacy compared to…”
    Get full text
    Journal Article
  6. 6

    Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients by Kern, Robert S, Green, Michael F, Marshall, Barringer D, Wirshing, William C, Wirshing, Donna, McGurk, Susan, Marder, Stephen R, Mintz, Jim

    Published in Biological psychiatry (1969) (15-10-1998)
    “…Background: The present study compared the effects of risperidone vs. haloperidol on reaction time, manual dexterity, and two types of motor learning in a…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Novel antipsychotics : Comparison of weight gain liabilities by WIRSHING, D. A, WIRSHING, W. C, KYSAR, L, BERISFORD, M. A, GOLDSTEIN, D, PASHDAG, J, MINTZ, J, MARDER, S. R

    Published in The journal of clinical psychiatry (01-06-1999)
    “…We performed a retrospective analysis of 122 clinical records of 92 male patients with DSM-III-R schizophrenia to examine the relative weight gain liabilities…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone by Green, Michael F, Marder, Stephen R, Glynn, Shirley M, McGurk, Susan R, Wirshing, William C, Wirshing, Donna A, Liberman, Robert P, Mintz, Jim

    Published in Biological psychiatry (1969) (15-06-2002)
    “…Background: Neurocognitive deficits are core features of schizophrenia that are linked to functional outcome for the disorder. Recent studies and reviews have…”
    Get full text
    Journal Article
  11. 11

    Supplementing Clinic-Based Skills Training With Manual-Based Community Support Sessions: Effects on Social Adjustment of Patients With Schizophrenia by Glynn, Shirley M., Marder, Stephen R., Liberman, Robert P., Blair, Karen, Wirshing, William C., Wirshing, Donna A., Ross, Doreen, Mintz, Jim

    Published in The American journal of psychiatry (01-05-2002)
    “…OBJECTIVE: Although skills training is a validated psychosocial treatment for schizophrenia, generalization of the skills to everyday life has not been…”
    Get full text
    Journal Article
  12. 12

    Maintenance Treatment of Schizophrenia With Risperidone or Haloperidol: 2-Year Outcomes by Marder, Stephen R., Glynn, Shirley M., Wirshing, William C., Wirshing, Donna A., Ross, Doreen, Widmark, Clifford, Mintz, Jim, Liberman, Robert P., Blair, Karen E.

    Published in The American journal of psychiatry (01-08-2003)
    “…OBJECTIVE: Most controlled studies comparing second-generation and conventional antipsychotics have focused on the acute treatment of schizophrenia. The…”
    Get full text
    Journal Article
  13. 13

    Informed Consent: Assessment of Comprehension by Wirshing, Donna A., Wirshing, William C., Marder, Stephen R., Liberman, Robert P., Mintz, Jim

    Published in The American journal of psychiatry (01-11-1998)
    “…Objective:The authors designed and evaluated a structured and rigorous informed consent procedure involving subjects with schizophrenia.Method:Informed consent…”
    Get full text
    Journal Article
  14. 14

    Sexual side effects of novel antipsychotic medications by Wirshing, Donna A, Pierre, Joseph M, Marder, Stephen R, Saunders, C.Scott, Wirshing, William C

    Published in Schizophrenia research (01-07-2002)
    “…Background: The novel antipsychotic medications offer a more favorable extrapyramidal side effect profile than conventional agents. It is uncertain that the…”
    Get full text
    Journal Article
  15. 15

    Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia by McGurk, Susan R, Green, Michael F, Wirshing, William C, Wirshing, Donna Ames, Marder, Steven R, Mintz, Jim, Kern, Robert

    Published in Schizophrenia research (01-06-2004)
    “…Spatial memory is of interest in schizophrenia because of widespread impairments in adaptive functioning, including independent living skills. Short-term…”
    Get full text
    Journal Article
  16. 16

    Risperidone-associated new-onset diabetes by Wirshing, Donna A, Pierre, Joseph M, Eyeler, Jerry, Weinbach, Julie, Wirshing, William C

    Published in Biological psychiatry (1969) (15-07-2001)
    “…Background: Weight gain, and its associated complications such as the development of diabetes, is becoming increasingly recognized as an important potential…”
    Get full text
    Journal Article
  17. 17

    Risperidone in Treatment-Refractory Schizophrenia by Wirshing, Donna A., Marshall, Jr, Barringer D., Green, Michael F., Mintz, Jim, Marder, Stephen R., Wirshing, William C.

    Published in The American journal of psychiatry (01-09-1999)
    “…OBJECTIVE: The purpose of this study was to evaluate the clinical safety and efficacy of risperidone compared to haloperidol in patients with…”
    Get full text
    Journal Article
  18. 18

    Prevalence of the metabolic syndrome in veterans with schizophrenia by Meyer, Jonathan, Loh, Catherine, Leckband, Susan G, Boyd, Jennifer A, Wirshing, William C, Pierre, Joseph M, Wirshing, Donna

    Published in Journal of psychiatric practice (01-01-2006)
    “…The metabolic syndrome has become a focus of clinical attention due to its high prevalence in the United States (23%) and impact on cardiovascular risk, yet…”
    Get full text
    Journal Article
  19. 19

    Hepatitis B and C Among Veterans on a Psychiatric Ward by Tabibian, James H., Wirshing, Donna A., Pierre, Joseph M., Guzik, Lisa H., Kisicki, Michael D., Danovitch, Itai, Mena, Shirley J., Wirshing, William C.

    Published in Digestive diseases and sciences (01-06-2008)
    “…Hepatitis B and C are public health problems. Psychiatric patients may be at risk of hepatitis B and C exposure due to lifestyle and inadequate health care. We…”
    Get full text
    Journal Article
  20. 20